What is the risk of prostate cancer if a patient has a normal PSA but an abnormal DRE?

29th October 2021

Missed our GatewayC Live webinar? Watch our specialists answer to this audience question and many more.

This week, GatewayC met Mr Sotonye Tolofari, Consultant Urological Surgeon, and Mr Alex Hoyle, Consultant Urologist. Our specialists covered ‘Urological Cancers’ and focused on prostate, bladder and kidney cancers.

Our speakers answered key questions from our audience which included:

  • Is obesity associated with an increased risk of prostate cancer?
  • What will reduce the risk of bladder and kidney cancer?
  • Should I complete an annual DRE, in addition to PSA monitoring for a borderline PSA?
  • What is the risk of prostate cancer if a patient has a normal PSA but an abnormal DRE?
  • What would count as non-visible haematuria?
  • Where can primary care professionals find guidance on non-visible haematuria?
  • What counts as a recurrent UTI?
  • What are the risk factors and red flags for both testicular and penile cancers?

Find out more:

  • Access GatewayC’s full webinar library here
  • Watch this recorded webinar here
  • Explore The British Association of Urological Surgeons here

LinkedIn | Twitter | Facebook

Latest from the Blog

Thrombocytosis and cancer

Thrombocytosis and cancer

11th February 2022 The British Journal of General Practice suggests thrombocytosis is a risk marker of cancer in adults and is worthy of further investigation. Lung and colorectal cancer were the most commonly diagnosed cancers. There is a stronger association between...

read more
Headache: symptom of a brain tumour?

Headache: symptom of a brain tumour?

26th January 2022 Headaches alone are a very uncommon presentation of brain tumours, with only 7% of brain tumour patients presenting with just a headache. However, most patients will experience them at some point in their brain tumour journey. Headaches that are...

read more

Related Posts

What tests should I do to diagnose myeloma?

What tests should I do to diagnose myeloma?

8th October 2021 Missed our GatewayC Live webinar? Watch our specialists answer to this audience question and many more. This week GatewayC met Dr Neil Rabin, Consultant Haematologist, and Dr Margaret Harris, Consultant Clinical Oncologist. Our specialists covered the...

read more
NEW GATEWAYC COURSE: Supporting Your Patients

NEW GATEWAYC COURSE: Supporting Your Patients

26th August 2021 We are delighted to announce that GatewayC's ‘Supporting Your Patients’ course is now available to all healthcare professionals across England. A cancer diagnosis can have a significant impact on an individual’s life. Our new course explores how...

read more